Skip to main content
OpenTrials

Clinical trial condition

Recurrent Adult Acute Myeloid Leukemia

Explore clinical trials studying Recurrent Adult Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

142 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Adult Acute Myeloid Leukemia trial results

Completed

Ixazomib, Mitoxantrone Hydrochloride, Etoposide, and Intermediate-Dose Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia

NCT02070458

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
Locations
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
View Trial Details
Completed

Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia

NCT00666588

Conditions
Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), +31 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
View all 82 locations
View Trial Details

Related conditions